Ethics statement The study, involving humans, was approved by the Ethics Committee of the Faculty of Medicine of Prince of Songkla University
Category S4 on the WADA Prohibited List also presents one of the biggest grey areas when it comes to interpreting the list language as it has 'including but not limited to' language that could cover any substance that may qualify in the the category based on activity
Cagrilintide (Cagri), functioning as a dual amylin receptor (AMYRs) and calcitonin receptor (CTR) agonist (DACRA), demonstrates significant efficacy in obesity treatment, although its structural activation mechanism remains unclear
Risk of progression depends on several factors Patients with high-grade dysplasia can immediately be flagged for treatment because they have a clear elevated risk of progression to cancer
That advantage is mechanistic rather than product-specific
Morgan is a wealth of information, and we had a wonderful discussion
